Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.
2.

Proteomic analysis of peripheral blood mononuclear cells: selective protein processing observed in patients with rheumatoid arthritis.

Schulz M, Dotzlaw H, Mikkat S, Eggert M, Neeck G.

J Proteome Res. 2007 Sep;6(9):3752-9. Epub 2007 Aug 17.

PMID:
17705417
3.

No effects of adalimumab therapy on the activation of NF-kappaB in lymphocytes from patients with severe rheumatoid arthritis.

Semmler M, Seeck U, Neustadt B, Schulz M, Dotzlaw H, Neeck G, Eggert M.

Clin Rheumatol. 2007 Sep;26(9):1499-504. Epub 2007 Feb 2.

PMID:
17273811
4.

An evaluation of anti-TNF-alpha-therapy in patients with ankylosing spondylitis: imbalanced activation of NF kappa B subunits in lymphocytes and modulation of serum cortisol concentration.

Eggert M, Seeck U, Semmler M, Maass U, Dietmann S, Schulz M, Dotzlaw H, Neeck G.

Rheumatol Int. 2007 Jul;27(9):841-6. Epub 2007 Jan 23.

PMID:
17242904
5.

Spots, blots, peaks and chips: proteomic approaches in autoimmune diseases.

Dotzlaw H, Eggert M, Neeck G, Schulz M.

Curr Pharm Des. 2006;12(29):3699-706. Review.

PMID:
17073669
6.

Co-activator and co-repressor interplay on the human androgen receptor.

Papaioannou M, Reeb C, Asim M, Dotzlaw H, Baniahmad A.

Andrologia. 2005 Dec;37(6):211-2. No abstract available.

PMID:
16336251
7.

Agonist-antagonist induced coactivator and corepressor interplay on the human androgen receptor.

Dotzlaw H, Papaioannou M, Moehren U, Claessens F, Baniahmad A.

Mol Cell Endocrinol. 2003 Dec 31;213(1):79-85.

PMID:
15062576
8.
9.

Expression analysis of the glucocorticoid receptor and the nuclear factor-kB subunit p50 in lymphocytes from patients with rheumatoid arthritis.

Eggert M, Klüter A, Rusch D, Schmidt KL, Dotzlaw H, Schulz M, Pabst W, Böke J, Renkawitz R, Neeck G.

J Rheumatol. 2002 Dec;29(12):2500-6.

PMID:
12465142
10.

Protein-protein cross-linking in the use of the eukaryotic eGST-fusion system.

Papaioannou M, Ruppert T, Dotzlaw H, Dressel U, Baniahmad A.

Protein Expr Purif. 2002 Dec;26(3):462-6.

PMID:
12460771
11.

Involvement of the glucocorticoid receptor in the pathogenesis of rheumatoid arthritis.

Neeck G, Kluter A, Dotzlaw H, Eggert M.

Ann N Y Acad Sci. 2002 Jun;966:491-5. Review.

PMID:
12114309
12.

Gene regulation by thyroid hormone receptors.

Dotzlaw H, Baniahmad A.

Methods Mol Biol. 2002;202:109-28. No abstract available.

PMID:
12094600
13.

The amino terminus of the human AR is target for corepressor action and antihormone agonism.

Dotzlaw H, Moehren U, Mink S, Cato AC, Iñiguez Lluhí JA, Baniahmad A.

Mol Endocrinol. 2002 Apr;16(4):661-73.

PMID:
11923464
14.
15.

Altered expression of estrogen receptor coregulators during human breast tumorigenesis.

Murphy LC, Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A, Watson PH.

Cancer Res. 2000 Nov 15;60(22):6266-71.

16.

Lumican and decorin are differentially expressed in human breast carcinoma.

Leygue E, Snell L, Dotzlaw H, Troup S, Hiller-Hitchcock T, Murphy LC, Roughley PJ, Watson PH.

J Pathol. 2000 Nov;192(3):313-20.

PMID:
11054714
17.

Functional characteristics of a novel murine estrogen receptor-beta isoform, estrogen receptor-beta 2.

Lu B, Leygue E, Dotzlaw H, Murphy LJ, Murphy LC.

J Mol Endocrinol. 2000 Oct;25(2):229-42.

PMID:
11013349
18.

Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers.

Simon SL, Parkes A, Leygue E, Dotzlaw H, Snell L, Troup S, Adeyinka A, Watson PH, Murphy LC.

Cancer Res. 2000 Jun 1;60(11):2796-9.

19.

Influence of estrogen receptor variants on the determination of ER status in human breast cancer.

Huang A, Leygue E, Dotzlaw H, Murphy LC, Watson PH.

Breast Cancer Res Treat. 1999 Dec;58(3):219-25.

PMID:
10718484
20.

Estrogen receptor-alpha mRNA variants in murine and human tissues.

Lu B, Dotzlaw H, Leygue E, Murphy LJ, Watson PH, Murphy LC.

Mol Cell Endocrinol. 1999 Dec 20;158(1-2):153-61.

PMID:
10630415
21.

Expression of the steroid receptor RNA activator in human breast tumors.

Leygue E, Dotzlaw H, Watson PH, Murphy LC.

Cancer Res. 1999 Sep 1;59(17):4190-3.

22.

The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue.

Dotzlaw H, Leygue E, Watson P, Murphy LC.

Clin Cancer Res. 1999 Aug;5(8):2103-7.

23.

Mammaglobin, a potential marker of breast cancer nodal metastasis.

Leygue E, Snell L, Dotzlaw H, Hole K, Troup S, Hiller-Hitchcock T, Murphy LC, Watson PH.

J Pathol. 1999 Sep;189(1):28-33.

PMID:
10451484
24.
25.

Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue.

Leygue E, Dotzlaw H, Watson PH, Murphy LC.

Cancer Res. 1999 Mar 15;59(6):1175-9.

26.

Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases.

Leygue E, Hall RE, Dotzlaw H, Watson PH, Murphy LC.

Br J Cancer. 1999 Feb;79(5-6):978-83.

28.

Estrogen receptor beta: mine is longer than yours?

Leygue E, Dotzlaw H, Lu B, Glor C, Watson PH, Murphy LC.

J Clin Endocrinol Metab. 1998 Oct;83(10):3754-5. No abstract available.

PMID:
9768697
29.

The pathophysiological role of estrogen receptor variants in human breast cancer.

Murphy LC, Dotzlaw H, Leygue E, Coutts A, Watson P.

J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):175-80. Review.

PMID:
9699871
30.

Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis.

Leygue E, Dotzlaw H, Watson PH, Murphy LC.

Cancer Res. 1998 Aug 1;58(15):3197-201.

31.

Estrogen receptor-beta mRNA variants in human and murine tissues.

Lu B, Leygue E, Dotzlaw H, Murphy LJ, Murphy LC, Watson PH.

Mol Cell Endocrinol. 1998 Mar 16;138(1-2):199-203.

PMID:
9685228
32.

Expression of lumican in human breast carcinoma.

Leygue E, Snell L, Dotzlaw H, Hole K, Hiller-Hitchcock T, Roughley PJ, Watson PH, Murphy LC.

Cancer Res. 1998 Apr 1;58(7):1348-52.

33.

Estrogen receptor variants and mutations.

Murphy LC, Dotzlaw H, Leygue E, Douglas D, Coutts A, Watson PH.

J Steroid Biochem Mol Biol. 1997 Aug;62(5-6):363-72. Review.

PMID:
9449239
34.

Expression of estrogen receptor-beta in human breast tumors.

Dotzlaw H, Leygue E, Watson PH, Murphy LC.

J Clin Endocrinol Metab. 1997 Jul;82(7):2371-4.

PMID:
9215322
35.

Oestrogen receptor variants and mutations in human breast cancer.

Murphy LC, Leygue E, Dotzlaw H, Douglas D, Coutts A, Watson PH.

Ann Med. 1997 Jun;29(3):221-34. Review.

PMID:
9240628
36.
37.

Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells.

Coutts AS, Davie JR, Dotzlaw H, Murphy LC.

J Cell Biochem. 1996 Nov 1;63(2):174-84.

PMID:
8913869
38.

Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue.

Leygue E, Dotzlaw H, Watson PH, Murphy LC.

Biochem Biophys Res Commun. 1996 Nov 1;228(1):63-8.

PMID:
8912636
39.

Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma.

Leygue E, Snell L, Hiller T, Dotzlaw H, Hole K, Murphy LC, Watson PH.

Cancer Res. 1996 Oct 15;56(20):4606-9. Erratum in: Cancer Res 1997 Feb 15;57(4):793.

40.

Novel mutations in the estrogen receptor messenger RNA in human breast cancers.

Murphy LC, Wang M, Coutt A, Dotzlaw H.

J Clin Endocrinol Metab. 1996 Apr;81(4):1420-7.

PMID:
8636345
41.
42.

Regulation of gene expression in T-47D human breast cancer cells by progestins and antiprogestins.

Murphy LC, Alkhalaf M, Dotzlaw H, Coutts A, Haddad-Alkhalaf B.

Hum Reprod. 1994 Jun;9 Suppl 1:174-80. Review.

PMID:
7962462
43.

Investigation of the origin of variant, truncated estrogen receptor-like mRNAs identified in some human breast cancer biopsy samples.

Murphy LC, Dotzlaw H, Hamerton J, Schwarz J.

Breast Cancer Res Treat. 1993;26(2):149-61.

PMID:
8219252
44.

Mechanisms of growth inhibition by antiestrogens and progestins in human breast and endometrial cancer cells.

Murphy LC, Dotzlaw H, Alkhalaf M, Coutts A, Miller T, Wong MS, Gong Y, Murphy LJ.

J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):117-21. Review.

PMID:
1525052
45.

Characterization of estrogen receptor variant mRNAs from human breast cancers.

Dotzlaw H, Alkhalaf M, Murphy LC.

Mol Endocrinol. 1992 May;6(5):773-85.

PMID:
1603086
46.

Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.

Murphy LC, Dotzlaw H, Wong MS, Miller T, Murphy LJ.

Cancer Res. 1991 Apr 15;51(8):2051-7.

47.

Isolation of histone-like proteins from mitochondria of bovine heart.

Yamada EW, Dotzlaw H, Huzel NJ.

Prep Biochem. 1991;21(1):11-23.

PMID:
1857681
48.

Epidermal growth factor: receptor and ligand expression in human breast cancer.

Murphy LC, Dotzlaw H, Wong MS, Miller T, Mrockowski B, Gong Y, Murphy LJ.

Semin Cancer Biol. 1990 Oct;1(5):305-15. Review.

PMID:
2103505
49.
50.

Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples.

Murphy LC, Dotzlaw H.

Mol Endocrinol. 1989 Apr;3(4):687-93.

PMID:
2725532

Supplemental Content

Loading ...
Support Center